Trump officials set new requirements for COVID vaccines in healthy adults and children

Published: Tuesday, May 20, 2025 at 3:29 pm

Trump Administration Shifts COVID-19 Vaccine Strategy, Focusing on High-Risk Groups

The Trump administration is implementing a significant policy change regarding COVID-19 vaccines, shifting away from routine annual shots for healthy adults and children. The Food and Drug Administration (FDA) announced new requirements for updated COVID-19 vaccines, prioritizing their availability for those most vulnerable to severe illness.

Under the new framework, annual COVID-19 shots will continue to be readily available for adults aged 65 and older, as well as younger adults and children with underlying health conditions that increase their risk. However, the FDA is now requiring pharmaceutical companies to conduct extensive, lengthy studies before approving updated vaccines for healthier individuals. This change could potentially limit the widespread availability of annual boosters for those not considered high-risk.

This shift raises questions about access and eligibility. Experts like Dr. Paul Offit have voiced concerns about how healthcare providers, such as pharmacists, will determine who qualifies for a vaccine under the new guidelines. The move also marks a departure from previous recommendations, which encouraged annual COVID-19 vaccine updates for most Americans, similar to the flu shot.

The FDA's new approach, outlined in the New England Journal of Medicine, reflects a broader scrutiny of COVID-19 vaccine policies under the Trump administration. The framework, written by FDA Commissioner Marty Makary and FDA vaccine chief Vinay Prasad, criticizes the U.S.'s "one-size-fits-all" approach and highlights the country's aggressive booster recommendations compared to European nations. The CDC's advisory panel is set to debate the question of yearly COVID-19 vaccinations next month.

BNN's Perspective: This policy change reflects a nuanced approach to COVID-19 vaccination, acknowledging the evolving understanding of the virus and the varying levels of risk within the population. While focusing resources on protecting the most vulnerable is a responsible strategy, it's crucial to ensure clear communication and accessibility for those who may still benefit from annual boosters, even if they don't fall into the high-risk categories. Striking a balance between public health and individual choice will be key moving forward.

Keywords: COVID-19 vaccine, FDA, Trump administration, vaccine policy, annual shots, boosters, high-risk groups, healthy adults, children, vaccine requirements, vaccine availability, Dr. Paul Offit, Marty Makary, Vinay Prasad, CDC, vaccine updates, health policy, healthcare, public health.

Full Story